HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kaple, R. K. Search for Related Content PubMed PubMed Citation Articles by Kaple, R. K. Related Collections Valve disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Massachusetts General Hospital, 55 Fruit St, Boston, MA 02114

(Email: rkaple@partners.org).

The first 20% of the full text of this article appears below.

This retrospective study by Khandhar and colleagues [1] evaluates the effect of aortic valve replacement (AVR) for severe aortic regurgitation (AR) in the setting of pulmonary hypertension (PHT). In this cohort of patients, AVR is safe and translates into a survival benefit at 5 years. Although the study is small, it offers a timely opportunity to reconsider indications for AVR and the underlying pathophysiology of left-heart causes of PHT.

Current American College of Cardiology/American Heart Association . . . [Full Text of this Article]

Related Article

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Regurgitation and Pulmonary Hypertension

Sumit Khandhar, Padmini Varadarajan, Rami Turk, Unnati Sampat, Reena Patel, Ashvin Kamath, and Ramdas G. Pai
Ann. Thorac. Surg. 2009 88: 752-756. [Abstract] [Full Text] [PDF]